May 16, 2017 / 11:59 AM / 6 months ago

BRIEF-Matinas BioPharma Q1 loss per share $0.25

May 16 (Reuters) - Matinas Biopharma Holdings Inc

* Matinas biopharma reports 2017 first quarter financial results and provides corporate update

* Q1 loss per share $0.25

* Matinas biopharma holdings inc - company ended quarter with cash and cash equivalents of approximately $15.8 million

* Matinas biopharma holdings inc - based on management’s current projections, co believes cash on hand is sufficient to fund operations into june 2018

* Matinas biopharma holdings - expects to report topline results from ongoing phase 2 study of mat2203 in vvc in june 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below